ArticlePloS one2026
Development of machine learning models for predicting early pregnancy outcomes based on β-hCG, progesterone, and estradiol.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to develop a machine learning model for predicting early pregnancy outcomes by combining baseline levels and dynamic changes of β-human chorionic gonadotropin (β-hCG), progesterone (P), and estradiol (E2).
methodsThis retrospective study screened out 421 patients treated at the Lanzhou University Second Hospital between March 2023 and August 2024. Feature selection was performed using Least Absolute Shrinkage and Selection Operator (LASSO) and Random Forest Recursive Feature Elimination (RF-RFE). Subsequently, we constructed a traditional logistic regression model and five machine learning models: Random Forest (RF), eXtreme Gradient Boosting (XGBoost), k-Nearest Neighbors (KNN), Multilayer Perceptron (MLP) neural network, and Support Vector Machine (SVM). Internal validity was assessed through 5-fold cross-validation. Model performance was measured by the area under the Receiver Operating Characteristic curve (AUC), accuracy, precision, sensitivity, and specificity.
resultsAmong the 421 enrolled patients, 263 had ongoing pregnancies while 158 experienced early pregnancy loss (EPL). LR, RF, XGBoost, KNN, MLP, and SVM achieved AUCs of 0.750, 0.784, 0.750, 0.706, 0.755, and 0.749, respectively, with all accuracy and precision metrics exceeding 0.60. Notably, the RF model yielded optimal performance for EPL prediction, attaining the highest AUC (0.784), accuracy (0.729), and precision (0.724).
conclusionIntegrating dynamic changes in β-hCG, P, and E2 enables effective prediction of early pregnancy outcomes. The RF model exhibited optimal performance, highlighting its potential for clinical implementation as a risk stratification tool based on serial hormone monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.